Physician profile
Ben Tseng
NPI 1710206347
$11,522.21
in general payments reported to CMS, 2019-2025
58 companies · $1,956 in 2025
The $1,956 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,033 · 2020: $1,131 · 2021: $1,298 · 2022: $1,476 · 2023: $1,876 · 2024: $1,752 · 2025: $1,956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,475 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,475.24 |
| Education | $108.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,984.89 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Novartis Pharmaceuticals Corporation | $1,173.35 | 2019-2025 | |
| Csl Behring | $657.91 | 2019-2025 | Hizentra, Kcentra |
| Lilly USA, LLC | $651.23 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Allergan, INC. | $527.72 | 2019-2022 | |
| Ucb, INC. | $517.20 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Biogen, INC. | $476.42 | 2019-2025 | Leqembi, Vumerity, Tysabri |
| Amgen INC. | $454.13 | 2019-2024 | Uplizna, Aimovig |
| Mdd US Operations, LLC | $417.54 | 2019-2025 | Gocovri, Gocovri, Apokyn |
| Acadia Pharmaceuticals INC | $379.89 | 2019-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $372.15 | 2019-2025 | Ultomiris, Soliris |
| Celgene Corporation | $326.03 | 2023-2025 | Zeposia |
| Amneal Pharmaceuticals LLC | $325.58 | 2019-2025 | Crexont, Rytary |
| Emd Serono, INC. | $311.41 | 2019-2025 | Mavenclad |
| Lundbeck LLC | $287.29 | 2020-2025 | Vyepti |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.